MARKET

SGRY

SGRY

Surgery Partners
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.55
-1.97
-8.38%
After Hours: 21.50 -0.05 -0.23% 17:48 09/21 EDT
OPEN
22.61
PREV CLOSE
23.52
HIGH
23.22
LOW
21.00
VOLUME
855.45K
TURNOVER
--
52 WEEK HIGH
24.75
52 WEEK LOW
4.000
MARKET CAP
1.09B
P/E (TTM)
-7.2413
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
NorthStar Anesthesia Completes Acquisition of Surgery Partners Anesthesia Services Business
NorthStar Anesthesia ("NorthStar" or the "Company"), one of the country's leading anesthesia care providers and managers, today announced that Anesthesia Consulting & Management, LP, has completed an acquisition of select anesthesia services businesses of Surgery Partners, Inc
PR Newswire · 6d ago
Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners
Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners
Zacks · 08/10 14:29
Surgery Partners, Inc.'s (SGRY) CEO Eric Evans on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/08 09:14
Surgery Partners EPS misses by $0.37, beats on revenue
Surgery Partners (NASDAQ:SGRY): GAAP EPS of -$0.86 misses by $0.37. Revenue of $382.6M (-15.5% Y/Y) beats by $48.62M. Shares -3% PM. Press Release
seekingalpha · 08/05 16:17
Surgery Partners (SGRY) Reports Q2 Loss, Tops Revenue Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of 5.88% and 1.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/05 14:05
Surgery Partners Q2 Adj. EPS $(0.48) Beats $(0.69) Estimate, Sales $374.70M Beat $342.07M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.69) by 30.43 percent. This is a 65.52 percent decrease over losses of $(0.29) per share from
Benzinga · 08/05 11:13
Surgery Partners Q2 Adj. EPS $(0.48) Beats $(0.69) Estimate, Sales $374.70M Beat $342.07M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.69) by 30.43 percent. This is a 65.52 percent decrease over losses of $(0.29) per share from
Benzinga · 08/05 11:13
Surgery Partners, Inc. Announces Second Quarter 2020 Results
BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2020. *
GlobeNewswire · 08/05 11:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SGRY stock price target is 23.25 with a high estimate of 28.00 and a low estimate of 17.50.
EPS
Institutional Holdings
Institutions: 155
Institutional Holdings: 51.03M
% Owned: 100.95%
Shares Outstanding: 50.55M
TypeInstitutionsShares
Increased
24
1.13M
New
44
2.41M
Decreased
29
1.52M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-2.06%
Healthcare Providers & Services
-2.69%
Key Executives
Chairman/Executive Director
Wayne DeVeydt
Chief Executive Officer/Director
J. Eric Evans
Chief Financial Officer/Executive Vice President
Thomas Cowhey
Corporate Executive
George Goodwin
Corporate Executive
Bradley Owens
Chief Human Resource Officer/Senior Vice President
Laura Brocklehurst
Executive Vice President/Chief Administrative Officer
Jennifer Baldock
Other
Anthony Taparo
Director
Clifford Adlerz
Independent Director
John Deane
Independent Director
Teresa DeLuca
Independent Director
Andrew Kaplan
Independent Director
T. Devin O'Reilly
Independent Director
Brent Turner
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More

Analyst Price Target

The average SGRY stock price target is 23.25 with a high estimate of 28.00 and a low estimate of 17.50.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SGRY
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company's Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company's surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company's Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company's physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company's Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Surgery Partners Inc stock information, including NASDAQ:SGRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SGRY stock methods without spending real money on the virtual paper trading platform.